TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioNema AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,000
|
3,279
|
2,407 |
| Financial expenses |
2
|
2
|
5 |
| Earnings before taxes |
1,185
|
318
|
310 |
| EBITDA |
1,246
|
381
|
401 |
| Total assets |
3,255
|
2,473
|
2,152 |
| Current assets |
1,346
|
2,034
|
1,710 |
| Current liabilities |
323
|
310
|
184 |
| Equity capital |
2,932
|
2,163
|
1,968 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.1%
|
87.5%
|
91.4% |
| Turnover per employee |
2,000
|
1,640
|
1,204 |
| Profit as a percentage of turnover |
29.6%
|
9.7%
|
12.9% |
| Return on assets (ROA) |
36.5%
|
12.9%
|
14.6% |
| Current ratio |
416.7%
|
656.1%
|
929.3% |
| Return on equity (ROE) |
40.4%
|
14.7%
|
15.8% |
| Change turnover |
662
|
701
|
-885 |
| Change turnover % |
20%
|
27%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.